Abstract:
An input device includes a supporting unit which is provided with first shafts, and a rotating unit is connected to the first shafts in a rotatable manner. In addition, an operating unit is provided with second shafts, and the rotating unit is also connected to the second shafts in a rotatable manner. When the operating unit is at an operating position, it is closely attached to an input unit provided on the front surface of a mobile phone. When the operating unit is at a stored position, the second shafts of the operating unit is moved from the front side of a mobile phone to the back side thereof, so that the operating unit is closely attached to the back surface of the mobile phone.
Abstract:
A keyboard device includes a plurality of keyswitches each having a keytop movable up and down, wherein the angle of the keytop varies depending on whether the keytop is in an initial position or in a pressed position. In this structure, the keytop moves in a direction corresponding to the motion of an operator's finger and thus smooth operations can be achieved, as opposed to a conventional keyboard device in which a keytop moves vertically while maintaining itself horizontal and thus the motion of the keytop occurs in a direction different from the motion of an operator's finger.
Abstract:
In conventional keyboard devices, since an elastic member is disposed between an insulating substrate and the central crossing part of levers, it is impossible to realize a thin keyswitch, and a high cost is required to modify the height of the keyswitch to a desired value required in a specific application. The invention provides a keyboard device having no such problems. In the keyboard device of the invention, a first and second levers are combined with each other via a shaft such that they cross each other; an elastic member is disposed in a hollow formed in the first or second lever; and the top portion of the elastic member is in contact with the pedestal formed on the back surface of the keytop. This structure allows a reduction in space between the keytop and the top portion of the elastic member. Thus, it is possible to realize a thin-type keyboard device, and it is also possible to accommodate the requirement of various heights of keyswitches simply by making a modification on the keytop. This allows a reduction in production cost.
Abstract:
A drying equipment includes an equipment body including a vapor bath, carrier for carring a semiconductor wafer, receiver tray, inert gas supply unit, cooling pipe, exhaust unit, transportation unit, control unit, etc. An air supply opening of a blower is opposite to a top opening of the vapor bath. The vapor bath contains an organic solvent therein. A vapor is generated by heating the organic solvent. A vapor phase boundary surface is formed on the boundary between the vapor and air overlying the same. When the wafer at low temperature is put into the vapor bath by means of the transportation unit, the organic solvent vapor condenses on the surface of the wafer. The inert gas supply unit supplies an inert gas to the vapor in the vapor bath. The wafer is pulled up slowly from the vapor by means of the transportation unit, and passes the vapor phase boundary surface on the way.
Abstract:
4-Imidazoline derivatives represented by the formula (I) and/or formula (II): ##STR1## wherein R.sup.1 represents C.sub.1 -C.sub.8 alkyl, C.sub.3 -C.sub.8 alkenyl, C.sub.3 -C.sub.8 alkynyl, C.sub.3 -C.sub.8 cycloalkyl, or optionally substituted aralkyl; R.sup.2 and R.sup.3 independently represent hydrogen, C.sub.3 -C.sub.20 alkyl, C.sub.3 -C.sub.20 alkenyl, C.sub.3 -C.sub.20 alkynyl, C.sub.3 -C.sub.20 alkoxy, C.sub.3 -C.sub.20 alkenyloxy, C.sub.3 -C.sub.20 alkynyloxy, C.sub.3 -C.sub.8 cyloalkyl, C.sub.1 -C.sub.10 alkylthio, or optionally substituted aralkyl or aralkyloxy; R.sup.4 represents C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.8 cycloalkyl, or optionally substituted aralkyl; provided that R.sup.2 and R.sup.3 cannot be hydrogen at the same time, and pharmaceutically acceptable salts thereof. A pharmaceutical formulation containing the compound is also provided.
Abstract:
A method for manufacturing a piezoelectric film wafer includes a first processing step for carrying out an ion etching on a KNN piezoelectric film formed on a substrate by using a gas containing Ar, and a second processing step for carrying out a reactive ion etching by using a mixed etching gas containing a fluorine-based reactive gas and Ar after the first processing step.
Abstract:
There is provided a piezoelectric thin film element, comprising: a substrate 1; and a piezoelectric thin film 3 having an alkali niobium oxide-based perovskite structure represented by a composition formula (K1-xNax)yNbO3 provided on the substrate 1, wherein a carbon concentration of the piezoelectric thin film 3 is 2×1019/cm3 or less, or a hydrogen concentration of the piezoelectric thin film 3 is 4×1019/cm3 or less.
Abstract:
There is provided a piezoelectric film having an alkali niobate-based perovskite structure expressed by a general formula (NaxKyLiz)NbO3(0≦x≦1, 0≦y≦1, 0≦z≦0.2, x+y+z=1), wherein the alkali niobate has a crystal structure of a pseudo-cubic crystal, a tetragonal crystal, an orthorhombic crystal, a monoclinic crystal, a rhombohedral crystal, or has a crystal structure of coexistence of them, and when total of K—O bonding and K-Metal bonding is set as 100% in a binding state around K-atom of the alkali niobate, a K—O bonding ratio is 46.5% or more and a K-Metal bonding ratio is 53.5% or less, wherein the Metal indicates a metal atom included in the piezoelectric film.
Abstract translation:提供了一种由通式(NaxKyLiz)NbO3(0& nlE; x≦̸ 1,0& nlE; y≦̸ 1,0& nlE; z≦̸ 0.2,x + y + z = 1)表示的碱铌酸盐类钙钛矿结构的压电膜, 其中铌酸锂具有假立方晶体,四方晶体,正交晶体,单斜晶体,菱方晶体的晶体结构,或者具有共晶的晶体结构,并且当总共K-O键合 并且在铌酸碱钾的K原子附近的结合状态下将K金属键合设定为100%,K-O键合比为46.5%以上,K-金属键合比为53.5%以下,其中,金属 表示包含在压电膜中的金属原子。
Abstract:
A pyrimidone derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof: wherein X represents hydrogen atom and Y represents hydroxyl group, or X represents fluorine atom and Y represents hydrogen atom; R1 represents a C1-6 alkyl group; R2 represents a morpholin-4-yl group which may be substituted, or the like, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).
Abstract:
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein Z represents nitrogen atom, C—F or the like; R1 represents a C1-C3 alkyl group; Y represents oxygen atom or N—R7; R2, R3, R4, R5, R6 and R7 each independently represents hydrogen atom, a C1-C6 alkyl group, or a group represented by the formula (II): which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).